Skip to main content
. 2024 May 31;230(6):e1207–e1213. doi: 10.1093/infdis/jiae293

Figure 1.

Figure 1.

Human papillomavirus type 6 (HPV-6) E2, E4, E6, E7, and L1 antibody levels (median fluorescence intensity [MFI], mean ± standard deviation) among pregnant mothers in their third trimester at the baseline of the study, separately for seropositive and seronegative women. Cut-off for L1 seropositivity was MFI ≥200. Cut-off for E2, E4, E6, and E7 seropositivity was MFI ≥100. Abbreviation: n = number of the mothers stratified by their human papillomavirus serostatus.